HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of montelukast and MK-886 on hepatic ischemia-reperfusion injury in rats.

AbstractBACKGROUND:
Hepatic ischemia-reperfusion injury (I/R) may occur in transplantation, trauma, and elective hepatic resections. Leukotrienes have been shown to play a major role in hepatic I/R injury. Five-lipoxygenase enzyme is an important enzyme in the production of leukotrienes from arachidonic acid. MK-886 is an inhibitor of 5-lipoxygenase, and montelukast is a cysteinyl leukotriene receptor antagonist. The aim of this study was to investigate whether MK-886 and montelukast are effective in preventing hepatic I/R injury.
MATERIALS AND METHODS:
Rats were divided into five groups consisting of seven rats in each: (1) Control I/R, (2) Control-montelukast, (3) Control-MK-886, (4) I/R+montelukast, and (5) I/R+MK-886. Thirty min of total hepatic vascular occlusion and then 60 min reperfusion were performed to animals in groups 1, 4, and 5. In groups 2 and 4, montelukast, and in groups 3 and 5, MK-886 was applied intraperitoneally before and during the surgical procedures.
RESULTS:
Apoptosis in the liver and intestine decreased significantly in the I/R+montelukast and I/R+MK-886 groups compared with the I/R group. Tissue malondialdehyde levels and glutathione consumptions also decreased significantly in the I/R+montelukast and I/R+MK-886 groups compared with the I/R group. The difference in serum alanine aminotransferase and aspartate aminotransferase levels between the groups did not reach significance.
CONCLUSIONS:
Montelukast and MK-886 were found to be effective in prevention of liver and intestine injury by reducing apoptosis and oxidative stress in a hepatic I/R model. Anti-inflammatory properties and inhibition of lipid peroxidation by montelukast and MK-886 could be protective for these organs in I/R injury.
AuthorsGul Daglar, Turgut Karaca, Yunus Nadi Yuksek, Ugur Gozalan, Filiz Akbiyik, Cenk Sokmensuer, Bora Gurel, Nuri Aydin Kama
JournalThe Journal of surgical research (J Surg Res) Vol. 153 Issue 1 Pg. 31-8 (May 01 2009) ISSN: 1095-8673 [Electronic] United States
PMID18656901 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Cyclopropanes
  • Indoles
  • Leukotriene Antagonists
  • Lipoxygenase Inhibitors
  • Quinolines
  • Sulfides
  • MK-886
  • montelukast
Topics
  • Acetates (therapeutic use)
  • Animals
  • Cyclopropanes
  • Disease Models, Animal
  • Indoles (therapeutic use)
  • Leukotriene Antagonists (therapeutic use)
  • Lipoxygenase Inhibitors (therapeutic use)
  • Liver Diseases (prevention & control)
  • Male
  • Quinolines (therapeutic use)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (prevention & control)
  • Sulfides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: